We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Treatment of Asymptomatic Ventricular Dysrhythmia in Patients With schemic Heart Disease

Kenneth M. Rosen, MD; Steven P. Swiryn, MD; Edwin A. Palileo, MD; Boris Strasberg, MD
Arch Intern Med. 1980;140(11):1419-1421. doi:10.1001/archinte.1980.00330220007005.
Text Size: A A A
Published online

In this issue (see p 1423), Whiting suggests that treatment of premature ventricular contractions is indicated in selected groups of patients (some asymptomatic) with chronic ischemic heart disease and ventricular dysrhythmia. The appeal of this approach is at least partially based on the premise that it is possible to identify patients with ischemic heart disease and a high risk of sudden death. Given the detection of high-risk groups, it does seem reasonable to assume that suppression of arrhythmia using antiarrhythmic drugs (with careful quantification of ventricular dysrhythmia) is appropriate.

However, we think that this suggested approach to the management of arrhythmia in ischemic heart disease patients should be subjected to further scrutiny. Our approach will be based on a statement of three premises that we believe are supportable based on our current state of knowledge.

Premise 1.  —Antiarrhythmic drugs are antiarrhythmic drugs, and not placebos. Quinidine sulfate, procainamide hydrochloride, disopyramide


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.